Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán

Chief Executive Officer

Linda Marbán

Collapse

Aj Bergmann

Chief Financial Officer

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Chief Development Officer (cdo)

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

Vice President Of Program Management, Operations And Quality

Joe Z.

Senior IP Counsel

Teams

+24

Research and Development

27 members

Leadership Team

3 members

Finance and Accounting

3 members

Similar companies

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Apogee Therapeutics

1 follower

Slingshot Biosciences

1 follower

Othram

1 follower

eGenesis

1 follower

Thermo Fisher Scientific

168 followers

Genentech

150 followers

Gilead Sciences

129 followers

Explore companies